CYP19A1 and polycystic ovary syndrome: Women with PCOS retain high circulating androgen levels throughout pregnancy, and these high circulating androgen levels are accompanied by altered placental function with lower aromatase expression potentially leading to higher testosterone exposure of the fetus [50].